Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system

Full text
Author(s):
Peloggia, Alessandra ; Petta, Carlos A. ; Bahamondes, Luis [3] ; Oliveira-Ribeiro, Marilia ; Zhang, Jin ; Salamonsen, Lois
Total Authors: 6
Document type: Journal article
Source: Human Reproduction; v. 21, n. 5, p. 1129-1134, May 2006.
Field of knowledge: Health Sciences - Medicine
Abstract

The objective was to assess endometrial chemokines in users of the levonorgestrel-releasing intrauterine system (LNG-IUS) and correlate them with leucocyte populations, uterine natural killer cells (uNK) and mast cells (MCs). Endometrium was obtained from two groups of women who had been using LNG-IUS for 3 years or more: 11 amenorrhoeic women formed the non-bleeding group and 15 women who maintained some form of cyclic bleeding comprised the bleeding group. Specific antibodies were used for the assessment of neutrophils, uNK cells and MCs. Immunohistochemistry was performed to locate the chemokines 6Ckine and interleukin-8 (IL-8). Neutrophils were few and without differences between the two groups. uNK cells were significantly higher in the bleeding group (P < 0.0001). There was no difference between the total number of MCs and activated MCs, but there was a greater extracellular area stained for MC tryptase (P < 0.05). Chemokines 6CKine and IL-8 were abundant in the stroma and in the epithelium, and there was no difference between the groups. We observed more uNK cells in users with bleeding and a greater extracellular area stained for MC tryptase, although there were no differences between the number of MCs and activated MCs or the chemokines 6CKine and IL-8. uNK cells and MC products may play a role in provoking breakthrough bleeding in long-term users of the LNG-IUS. (AU)

FAPESP's process: 03/08391-7 - Evaluation of the clinical and molecular repercussions of the use of contraceptives that contain only progestogen
Grantee:Luis Guillermo Bahamondes
Support Opportunities: Research Projects - Thematic Grants